Evidence map›Paper›PMID 30424181›Full record

ArticleMicromachines2018

Micro Droplet Formation towards Continuous Nanoparticles Synthesis.

Marek Wojnicki, Magdalena Luty-Błocho, Volker Hessel, Edit Csapó, Ditta Ungor, Krzysztof Fitzner

Abstract read
In one paragraph

Article in Micromachines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marek WojnickiFaculty of Non-Ferrous Metals, AGH University of Science and Technology, Al. A. Mickiewicza 30, 30-059 Krakow, Poland. marekw@agh.edu.pl.
Magdalena Luty-BłochoFaculty of Non-Ferrous Metals, AGH University of Science and Technology, Al. A. Mickiewicza 30, 30-059 Krakow, Poland. mlb@agh.edu.pl.ORCID 0000-0001-9018-7654
Volker HesselMicro Flow Chemistry and Process Technology, Department of Chemical Engineering and Chemistry, Technische Universiteit Eindhoven, P.O. Box 513, 5600 MB Eindhoven, The Nederland. v.hessel@tue.nl.
Edit CsapóMTA-SZTE Biomimetic Systems Research Group, Department of Medical Chemistry, Faculty of Medicine, University of Szeged, Dóm tér 8., 6720 Szeged, Hungary. tidecs2000@yahoo.co.uk.
Ditta UngorMTA-SZTE Biomimetic Systems Research Group, Department of Medical Chemistry, Faculty of Medicine, University of Szeged, Dóm tér 8., 6720 Szeged, Hungary. ungord@chem.u-szeged.hu.
Krzysztof FitznerFaculty of Non-Ferrous Metals, AGH University of Science and Technology, Al. A. Mickiewicza 30, 30-059 Krakow, Poland. fitzner@agh.edu.pl.

Funding

Ministry of Science and Higher Education under the name "Iuventus Plus" No. 0517 / IP2 / 2015/73
6 · The paper itself

Abstract

In this paper, micro droplets are generated in a microfluidic focusing contactor and then they move sequentially in a free-flowing mode (no wall contact). For this purpose, two different micro-flow glass devices (hydrophobic and hydrophilic) were used. During the study, the influence of the flow rate of the water phase and the oil phase on the droplet size and size distribution was investigated. Moreover, the influence of the oil phase viscosity on the droplet size was analyzed. It was found that the size and size distribution of the droplets can be controlled simply by the aqueous phase flow rate. Additionally, 2D simulations to determine the droplet size were performed and compared with the experiment.

Indexed as

Comsol Multiphysicsdropletsmicroreactorsequential flowsimulations of 2D flowtwo-phase flow

Identifiers

PMID30424181
PMCPMC6187485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.